Podcast appearances and mentions of elaine mardis

00:00 Show Open / Blythe Thomas, Initiative Director for 1,000 Days, which advocates for children in daycare. 12:00 Courtesy of our sister station, WBNS 10-TV, Kevin Landers sits down with Governor Mike DeWine for a discussion about abortion, taxes, the death penalty, and more. And Ohio's Democratic U.S. Senator Sherrod Brown looks back at 2022. 36:30 Elaine Mardis, PhD, Co-Executive Director of the Institute for Genomic Medicine at Nationwide Children's Hospital.

Dr Rick Wilson and Dr Elaine Mardis visit the studio as we consider the basics of genomic medicine. Learn how DNA is sequenced, explored and used to inform the diagnosis, prognosis and management of human disease. We hope you can join us!

Elaine Mardis and Lillian Siu speak with senior editor Markus Elsner about the current state of precision cancer medicine and what progress the future might hold. See acast.com/privacy for privacy and opt-out information.

Part I of the annual meeting of the American Association for Cancer Research—it was all virtual—had 61,000 attendees. Part II is about to start. Here's a sneak peek about the meeting, its hundreds of talks and thousands of posters. Virtual conferences mean less of a carbon footprint, maybe a broader reach and a chance for attendees who cannot typically travel to AACR to attend virtually.  Commenting on AACR II and about virtual conferences more generally: Dr. Elaine Mardis: the current president of the American Association for Cancer Research. She is co-Executive Director of the Institute for Genomic Medicine at Nationwide Children's Hospital and the Nationwide Foundation Endowed Chair in Genomic Medicine. And Dr. Antoni Ribas, the incoming AACR president. He is at the University of California Los Angeles. He directs the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center and is director of the Parker Institute for Cancer Immunotherapy Center at UCLA. 

Elaine Mardis discusses how next generation sequencing technology is helping the Pan-Cancer Initiative gain a molecular understanding of cancer.

The first draft of the human genome came with a price tag running into billions of dollars. In less than twenty years, the cost of whole genome sequencing had plummeted, making the thousand dollar genome a reality by 2014, and opening up a consumer market for personal genome sequencing - although as geneticist Elaine Mardis quipped, it’s a $1000 genome, and a £100,000 analysis. The price for sequencing continues to fall, and several companies are vying to be the first to break the hundred dollar barrier.But, according to George Church, professor of genetics at Harvard Medical School and one of the world’s leading authorities on genes and genomes, we’re about to see the dawn of the zero dollar genome, making personal whole genome sequencing effectively free in exchange for the data.We also chat with genomics researcher Manuel Corpas about how his experience of personal genome sequencing became very personal once he got his whole family involved, particularly when everyone started competing to see who had the 'best' genes. Genetics Unzipped is written and presented by Kat Arney, and produced by First Create the Media for the Genetics Society - one of the oldest learned societies in the world dedicated to supporting and promoting the research, teaching and application of genetics. Production by Hannah Varrall.Full show notes and links available at https://geneticsunzipped.com/blog/2019/5/9/the-zero-dollar-genome

Dr Mardis speaks with ecancer at WIN 2016 about widening access to next-generation sequencing as part of clinical practice. She discusses barriers to accessing sequencing data, such as different models of insurance and reimbursement across the world, private companies which offer sequencing services, and determining actionable information from sequencing data. She highlights the value of open-source collaboration among oncologists to share and maximise the usefulness of genomic data, and anticipates its wider use alongside other new technologies.

Elaine Mardis discusses how next generation sequencing technology is helping the Pan-Cancer Initiative gain a molecular understanding of cancer.

Elaine Mardis explores the Orangutan genome, and Ed Green explains how and what we know about our relation to Neandertal. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Science] [Show ID: 21954]

Elaine Mardis explores the Orangutan genome, and Ed Green explains how and what we know about our relation to Neandertal. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Science] [Show ID: 21954]

Elaine Mardis, Associate Professor of Genetics at Washington University and Senior Research Scientist at Bio-Rad Laboratories, explores the orangutan genome. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Science] [Show ID: 21980]

Elaine Mardis, Associate Professor of Genetics at Washington University and Senior Research Scientist at Bio-Rad Laboratories, explores the orangutan genome. Series: "CARTA - Center for Academic Research and Training in Anthropogeny" [Science] [Show ID: 21980]